Key facts
- Lind Global Fund III LP filed SCHEDULE 13G for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 10%.
- Date of event: 28 Jan 2026.
Lind Global Fund III LP - 28 Jan 2026 SCHEDULE 13G Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing manager
- Lind Global Fund III LP
- Reporting owner
- Lind Global Fund III LP
- Beneficially owned shares
- 141,265 shares
- Class ownership
- 10%
- Symbol
- ENVB
- Shares outstanding
- 1,414,064 shares
- Form type
- SCHEDULE 13G
- Accepted by SEC
- 04 Feb 2026, 16:31:39 UTC
- Event date
- 28 Jan 2026
- Next filing
- 15 May 2026
- SEC filing
- View on sec.gov
Ownership signal
1 fact
Subject security
2 facts
SEC evidence
5 facts
Key filing fact
Lind Global Fund III LP disclosed 10% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 28 Jan 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2026, 16:31.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lind Global Fund III LP | 10% | 141,265 | 141,265 | 0 | By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Lind Global Partners III LLC | 10% | 141,265 | 141,265 | 0 | /s/ Jeff Easton | Jeff Easton, Managing Member | |
| EASTON JEFF | 10% | 141,265 | 141,265 | 0 | /s/ Jeff Easton | Jeff Easton |
CIK / CUSIP context first